Meet the 2019 Medtech Insight Awards Judges
Our commitment to awards entrants and attendees is bound up in the selection of judges who volunteer their time, experience and consideration of the hundreds of entries to our various annual global awards.
The judges, invited from all core sectors of the medtech and pharma industries, engage in the judging process independently, combining their industry knowledge to score entries against the entry criteria. The judges' scores are all combined, giving us the shortlist and winners.
Without judges’ depth of knowledge and passion for supporting the medtech industry, the Medtech Insight Awards would not be possible.
We take this opportunity to thank all our judges for their role in helping to ensure the integrity of the Medtech Insight Awards.
The 2019 judging panel is being confirmed and currently consists of:
Chief Executive Officer
Mr Bernasconi has more than 30 years experience in the world of pharmaceuticals and medical devices, working in companies such as Johnson & Johnson, Schering Plough in US and Europe, and more recently Medtronic.
In his capacity as President & International Regional Vice President of Medtronic France, he was elected President of APIDIM (The French Association for the Promotion of Innovation in Medical Devices), and Vice President and Treasurer of SNITEM (French Medical Technology Industry Association).
Professional Staff, Cardiovascular Surgery
Texas Heart Institute
William E. Cohn, MD, is a Vice President of Medical Devices at Johnson&Johnson and the Executive Director for the Johnson & Johnson Center for Device Innovation at the Texas Medical Center. He is also a professor of surgery at Baylor College of Medicine and an adjunct professor of Bioengineering at both Rice University and the University of Houston.
Prior to joining J&J, Dr. Cohn was the director of the Cullen Cardiovascular Research Lab at the famed Texas Heart Institute and the Director of Minimally Invasive Cardiothoracic Surgery at THI. A native of Houston, Dr. Cohn received his medical school education, general surgical training, and cardiothoracic surgical training at Baylor College of Medicine where he served as the last chief resident of the legendary heart surgeon Michael E. DeBakey. After graduation, Dr. Cohn spent eleven years on the faculty of Harvard Medical School and as an Attending Cardiothoracic Surgeon at Boston’s Beth Israel Deaconess Medical Center.
His major research interests include the development of new technology for decreasing the invasiveness of surgical procedures and development of the continuous-flow totally implantable artificial heart. In 2011, Dr. Cohn and Dr. O. H. Frazier successfully implanted the first pulseless total heart replacement device in a human patient.
Fourth Element Capital
John Deedrick is an experienced senior executive, a venture investor, a thoughtful and value-added board member, a governance expert, a leadership coach and speaker, as well as an early stage company founder and advisor. His career encompasses venture investments in over 50 companies, a board director or board observer role in more than 30 companies, a co-founders role in 20 companies and significant operating roles for multiple businesses.
John is Co-founder and Executive Chairman of ActivOrtho, Inc., Co-Founder and Director of DyaMX, Inc., Co-Founder and Director of CHIP II, Inc. John is also President of CHIP Solutions, a business consulting firm that provides significant value-added services to individuals, private companies and public companies.
Chief Executive Officer
Medical Device Innovation Consortium
Director, Healthcare Policy
Richard joined the ABHI in June 2015 with over 20 years’ experience in the pharmaceutical and medical devices industries.
Richard holds a first degree in Sports Science from Brighton Polytechnic and a Master's in Health Economics Research and Management from Keele University. He served from 2003 until 2013 as a member of the Technology Appraisal Advisory Committee of the National Institute for Health and Care Excellence and also on the Programme Advisory Group of the Healthcare Quality and Information Authority in Ireland.
Richard is a non-Executive Director of both the West Midlands and South West Peninsula Academic Health Science Networks, serving as Chair of the latter for most of 2015. He also sits on the Board of the Royal Orthopaedic Hospital, Birmingham and Chairs the Programme Board of the Small Business Research Initiative Healthcare. He is a longstanding member of the Institute of Healthcare Management.
Randel has over 30 years’ experience working in health policy, reimbursement, economics, and data analytics for health service, technology and pharmaceutical companies. She presently serves as a Senior Advisor to Boston Biomedical Associates after serving as a senior advisor to Avalere in Washington DC. She successfully founded and sold The Neocure Group, a company providing data analytics, health economics, reimbursement strategic services for biotech, technology, pharmaceutical industry. Richner was Vice President, Global Government Affairs, Reimbursement, Boston Scientific Corporation (BSC), establishing the global reimbursement and economics function, expanding to national/international medical device legislative and regulatory, tax, and trade issues.
Richner has been actively engaged in policy initiatives with US Congress and CMS for many years,
serving a four-year term as the first industry representative, Executive Committee (EC) Medicare
Coverage Advisory Committee (MCAC). She has served on numerous boards including Executive Dean's Advisory Board, University of Michigan’s School of Public Health, MassMedic, founder of MassMedic Women in Medtech, Medical Device Industry Consortium (MDIC), International Society of Pharmacoeconomics and Research (ISPOR), founder of the US Medical Device Council of ISPOR, and Asia-Pacific Medical Device Council, Institute of Medicine (IOM) special committee on cost-effectiveness/post-market surveillance; Executive Advisory Board, Center for Evaluation Value, Risk in Health (CEVRH) Tufts New England Medical Center. She is an invited executive lecturer at Dartmouth, Tuck School of Business, University of Michigan School of Engineering and Pharmacy and a Griffith Leadership Fellow at the University of Michigan School of Public Health.
Vice President of Business Development, ximedica
In her role as Vice President of Business Development, Kristin partners with clients to translate strategic goals into robust operational plans that achieve objectives and satisfy the client’s interim and long-term milestones. With a background in both healthcare delivery solutions and medical device portfolio management, Kristin draws upon a wealth of experience steeped in market-focused strategy, key-stakeholder alignment, risk mitigation and meaningful governance.
After spending over a decade leading device business units for 3M, STERIS, and Covidien, Kristin most recently combined analytics, operational performance improvement, and clinical resourcing in helping hospitals define the approach and tactical plans needed to support the migration from fee-for-service to risk-based payment models.
Kristin holds an undergraduate Business degree from the University of Wisconsin and an MBA from the University of Minnesota.
Chief Innovation Officer & Corporate Outreach Officer
Penn Center for Innovation
Dr. Mark Turco is responsible for identifying, fostering and promoting University-wide innovations that will successfully translate into external commercial partnerships globally. In this role, Mark leads the Penn Center for Innovation corporate outreach efforts and also partners with Penn innovators to help them develop commercial connection strategies as well as helping to build out Philadelphia’s Innovation culture.